Anaplastic thyroid carcinoma (ATC) is a rare but highly lethal type of thyroid cancer with one of the worst survival rates of all malignancies, a median of only about 5 months after diagnosis. It is encouraging that advances in therapy, including the introduction of molecular-based personalized therapies and multimodal strategies, appear to be associated with significant increases in survival. However, ATC's low responsiveness to many treatments leaves a long way to go to improve outcomes for more patients with this aggressive malignancy.
How much do you know about the management of ATC? Test your knowledge with this quick quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Lori J. Wirth. Fast Five Quiz: Management of Anaplastic Thyroid Carcinoma - Medscape - Jun 21, 2023.